View Item 

Show simple item record

Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial
dc.contributor.authorZick, Suzanna M.en_US
dc.contributor.authorVautaw, Bonnie Motykaen_US
dc.contributor.authorGillespie, Brendaen_US
dc.contributor.authorAaronson, Keith D.en_US
dc.date.accessioned2014-02-11T17:57:23Z
dc.date.available2014-02-11T17:57:23Z
dc.date.issued2009-10en_US
dc.identifier.citationZick, Suzanna M.; Vautaw, Bonnie Motyka; Gillespie, Brenda; Aaronson, Keith D. (2009). "Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial." European Journal of Heart Failure 11(10): 990-999. <http://hdl.handle.net/2027.42/102717>en_US
dc.identifier.issn1388-9842en_US
dc.identifier.issn1879-0844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/102717
dc.publisherHippokrates Verlagen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherCrataegusen_US
dc.subject.otherHawthornen_US
dc.subject.otherHeart Failureen_US
dc.subject.otherSystolicen_US
dc.titleHawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trialen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelCardiovascular Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid19789403en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/102717/1/ejhfhfp116.pdf
dc.identifier.doi10.1093/eurjhf/hfp116en_US
dc.identifier.sourceEuropean Journal of Heart Failureen_US
dc.identifier.citedreferenceWeikl A Assmus KD Neukum‐Schmidt A Schmitz J Zapfe G Noh HS Siegrist J Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II) Fortschr Med 1996 114 291 296en_US
dc.identifier.citedreferenceBahorun T Aumjaud E Ramphul H Rycha M Luximon‐Ramma A Trotin F Aruoma OI Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts Nahrung 2003 47 191 198en_US
dc.identifier.citedreferenceMasquelier J Beal JL Reinhard E Pycnogenols: recent advances in the therapeutical activity of procyanidins Natural Products as Medicinal Agents: Plenary Lectures of the International Research Congress on Medicinal Plant Research, Stuttgart, July 1980 1981 Strasbourg Hippokrates Verlagen_US
dc.identifier.citedreferencePittler MH Schmidt K Ernst E Hawthorn extract for treating chronic heart failure: meta‐analysis of randomized trials Am J Med 2003 114 665 674en_US
dc.identifier.citedreferenceZick SM Gillespie B Aaronson KD The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure Eur J Heart Fail 2008 10 587 593en_US
dc.identifier.citedreferenceAaronson KD Schwartz JS Chen TM Wong KL Goin JE Mancini DM Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 1997 95 2660 2667en_US
dc.identifier.citedreferenceGroup TE EuroQoL‐A new facility for the measurement of health related quality of life Health Policy 1990 16 199 208en_US
dc.identifier.citedreferencePacker M Colucci WS Sackner‐Bernstein JD Liang CS Goldscher DA Freeman I Kukin ML Kinhal V Udelson JE Klapholz M Gottlieb SS Pearle D Cody RJ Gregory JJ Kantrowitz NE LeJemtel TH Young ST Lukas MA Shusterman NH Double‐blind, placebo‐controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial Circulation 1996 94 2793 2799en_US
dc.identifier.citedreferenceLeuchtgens H Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double‐blind study Fortschr Med 1993 111 352 354en_US
dc.identifier.citedreferenceO'Connolly M Jansen W Bernhoft G Bartsch G Treatment of decreasing cardiac performance. Therapy using standardized Crataegus extract in advanced age Fortschritte der Medizin 1986 104 805 808en_US
dc.identifier.citedreferenceHanack T Bruckel MH The treatment of mild stable forms of angina pectoris using Crategutt novo Therapiewoche 1983 33 4331 4333en_US
dc.identifier.citedreferenceZapfe G Clinical efficacy of Crataegus Extract WS 1442 in congestive heart failure NYHA Class II Phytomedicine 2001 8 262 266en_US
dc.identifier.citedreferenceBodigheimer K Chasa D Effectiveness of hawthorn extract at a dosage of 3 × 100 mg per day. Multicentre double‐blind trial with 85 NYHA stage II heart failure patients Munch Med Wschr 1994 136 S7 S11en_US
dc.identifier.citedreferenceO'Connolly VM Jansen W Bernhoft G Bartsch G Treatment of heart failure Fortschr Med 1986 104 805 808en_US
dc.identifier.citedreferenceTauchert M Efficacy and safety of Crataegus Extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association Class‐III heart failure Am Heart J 2002 143 910 915en_US
dc.identifier.citedreferenceTauchert M Ploch M Hubner W‐D Effectiveness of the hawthorn extract LI 132 compared with the ACE inhibitor captopril. Multicentre double‐blind study with 132 NYHA stage II heart failure patients Munchener Medizinische Wochenschrift 1994 136 S27 S33en_US
dc.identifier.citedreferenceStrauss P Ietta M Thomas S Fichman B The mean blood pressure—heart rate quotient and systolic blood pressure—heart rate product are not useful indicators of myocardial ischemia Anesthesiology 1989 71en_US
dc.identifier.citedreferenceBittner V Weiner DH Yusuf S Rogers WJ McIntyre KM Bangdiwala SI Kronenberg MW Kostis JB Kohn RM Guillotte M Prediction of mortality and morbidity with a 6 min walk test in patients with left ventricular dysfunction JAMA 1993 270 1702 1707en_US
dc.identifier.citedreferenceDemers C McKelvie R Negassa A Yusuf S RESOLVD Pilot Study Investigators. Reliability, validity, and responsiveness of the six‐minute walk test in patients with heart failure Am Heart J 2001 142 698 703en_US
dc.identifier.citedreferenceMancini DM Eisen H Kussmaul W Mull R Edmunds LH Wilson JR Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 1991 83 778 786en_US
dc.identifier.citedreferenceHolubarsch C Colucci W Meinertz T Gaus W Tendera M Crataegus extract WS® 1442, congestive heart failure, survival, efficacy, safety, controlled randomized trial Eur J Heart Failure 2008 10 1255 1263en_US
dc.identifier.citedreferenceWeihmayr T Ernst E Therapeutic effectiveness of Crataegus Fortschr Med 1996 114 27 29en_US
dc.identifier.citedreferenceGarjani A Nazemiyeh H Maleki N Valizadeh H Effects of extracts from flowering tops of Crataegus meyeri A. Pojark. on ischaemic arrhythmias in anaesthetized rats Phytother Res 2000 14 428 431en_US
dc.identifier.citedreferenceChatterjee SS Koch E Jaggy H Krzeminski T In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms Arzneimittel‐Forschung 1997 47 821 825en_US
dc.identifier.citedreferenceOcchiuto F Circosta C Briguglio F Tommasini A de Pasquale A Comparative study of the cardiovascular activity of shoots, leaves and flowers of Crataegus oxyacantha: 1. Electrical activity and arterial pressure in the rat Plantes medicinales et phytotherapie 1986 20 37 51en_US
dc.identifier.citedreferenceOcchiuto F Circosta C Costa R Briguglio F Tommasini A Comparative study of the cardiovascular activity of shoots, leaves and flowers of Crataegus oxyacantha: 2. Action of extracts and isolated pure active principles on the isolated rabbit heart Plantes medicinales et phytotherapie 1986 20 52 63en_US
dc.identifier.citedreferenceBrixius K Frank K Munch G Muller‐Ehmsen J Schwinger RHG WS 1442 ( Crataegus ‐Special Extract) increases contractile force in the myocardium of humans with congestive heart failure Herz‐Kreislauf 1998 30 28 33en_US
dc.identifier.citedreferenceRuchstuhl M Beretz A Anton R Landry Y Flavonoids are selective cyclic GMP phosphodiesterase inhibitors Biochem Pharmacol 1979 28 535 538en_US
dc.identifier.citedreferenceSchussler M Holzl J Fricke U Myocardial effects of flavonoids from Crataegus species Arzneimittelforschung 1995 45 842 845en_US
dc.identifier.citedreferencePeriera da Silva A Rocha R Silva CM Mira L Duarte MF Florencio MH Antioxidants in medicinal plant extracts. A research study of the antioxidant capacity of Crataegus, Hamamelis and Hydrastis. Phytother Res 2000 14 612 616en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ejhfhfp116.pdf
Size:
228.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.